These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 33807592)

  • 1. Pharmacogenetics Approach for the Improvement of COVID-19 Treatment.
    Fricke-Galindo I; Falfán-Valencia R
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics and COVID-19: clinical implications of human genome interactions with repurposed drugs.
    Badary OA
    Pharmacogenomics J; 2021 Jun; 21(3):275-284. PubMed ID: 33542445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
    Sahana S; Sivadas A; Mangla M; Jain A; Bhoyar RC; Pandhare K; Mishra A; Sharma D; Imran M; Senthivel V; Divakar MK; Rophina M; Jolly B; Batra A; Sharma S; Siwach S; Jadhao AG; Palande NV; Jha GN; Ashrafi N; Mishra PK; Vidhya AK; Jain S; Dash D; Kumar NS; Vanlallawma A; Sarma RJ; Chhakchhuak L; Kalyanaraman S; Mahadevan R; Kandasamy S; Devi P; Rajagopal RE; Ramya JE; Devi PN; Bajaj A; Gupta V; Mathew S; Goswami S; Prakash S; Joshi K; Kumla M; Sreedevi S; Gajjar D; Soraisham R; Yadav R; Devi YS; Gupta A; Mukerji M; Ramalingam S; Binukumar BK; Sivasubbu S; Scaria V
    Pharmacogenomics; 2021 Jul; 22(10):603-618. PubMed ID: 34142560
    [No Abstract]   [Full Text] [Related]  

  • 4. Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens.
    Lusiki Z; Blom D; Soko ND; Malema S; Jones E; Rayner B; Blackburn J; Sinxadi P; Dandara MT; Dandara C
    OMICS; 2024 Jun; 28(6):261-279. PubMed ID: 37956269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review.
    Kröker A; Tirzīte M
    Respir Res; 2021 Nov; 22(1):304. PubMed ID: 34838020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus.
    Costanzo M; De Giglio MAR; Roviello GN
    Curr Med Chem; 2020; 27(27):4536-4541. PubMed ID: 32297571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive association of
    Biswas M
    Pharmacogenomics; 2021 Apr; 22(6):375-381. PubMed ID: 33759544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenomics of COVID-19 therapies.
    Takahashi T; Luzum JA; Nicol MR; Jacobson PA
    NPJ Genom Med; 2020; 5():35. PubMed ID: 32864162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
    Franczyk B; Rysz J; Miłoński J; Konecki T; Rysz-Górzyńska M; Gluba-Brzózka A
    Pharmaceuticals (Basel); 2022 Jun; 15(6):. PubMed ID: 35745658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019.
    Kim JW; Kim EJ; Kwon HH; Jung CY; Kim KC; Choe JY; Hong HL
    Korean J Intern Med; 2021 Mar; 36(Suppl 1):S253-S263. PubMed ID: 32536150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral treatment of COVID-19.
    Şimşek Yavuz S; Ünal S
    Turk J Med Sci; 2020 Apr; 50(SI-1):611-619. PubMed ID: 32293834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies.
    Biswas M; Sawajan N; Rungrotmongkol T; Sanachai K; Ershadian M; Sukasem C
    Front Pharmacol; 2022; 13():835136. PubMed ID: 35250581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
    Hosseini FS; Malektojari A; Ghazizadeh S; Hassaniazad M; Davoodian P; Dadvand H; Nikpoor AR; Nikoofal-Sahlabadi S; Kahoori S; Sepandi M; Hassanipour S; Fathalipour M
    Trials; 2021 Jan; 22(1):4. PubMed ID: 33397429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19).
    Zubiaur P; Koller D; Saiz-Rodríguez M; Navares-Gómez M; Abad-Santos F
    Clin Transl Sci; 2020 Nov; 13(6):1023-1033. PubMed ID: 32936528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
    Rakedzon S; Neuberger A; Domb AJ; Petersiel N; Schwartz E
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33480414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update to living WHO guideline on drugs for covid-19.
    BMJ; 2020 Dec; 371():m4779. PubMed ID: 33334781
    [No Abstract]   [Full Text] [Related]  

  • 18. An in vitro study of dual drug combinations of anti-viral agents, antibiotics, and/or hydroxychloroquine against the SARS-CoV-2 virus isolated from hospitalized patients in Surabaya, Indonesia.
    Purwati ; Miatmoko A; Nasronudin ; Hendrianto E; Karsari D; Dinaryanti A; Ertanti N; Ihsan IS; Purnama DS; Asmarawati TP; Marfiani E; Yulistiani ; Rosyid AN; Wulaningrum PA; Setiawan HW; Siswanto I; Tri Puspaningsih NN
    PLoS One; 2021; 16(6):e0252302. PubMed ID: 34143818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus.
    Bhattacharyya P; Das S; Aich S; Sarkar J
    Front Biosci (Elite Ed); 2021 Dec; 13(2):272-290. PubMed ID: 34937314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions.
    Deb S; Reeves AA
    J Pharm Pharm Sci; 2021; 24():277-291. PubMed ID: 34107241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.